bioRxivMicrobiologyPreprint
A novel bacteriocin produced by Bifidobacterium longum subsp. infantis has dual antimicrobial and immunomodulatory activity
S. G. Javvadi, M. Kujawska, D. Papp, A. M. Gontarczyk, A. Jordan, M. A. Lawson, I. J. O'Neill, C. Alcon-Giner, R. Kiu, P. Clarke, N. Beraza, L. J. Hall
Abstract
Bacteriocins are ribosomally-synthesized antimicrobial peptides produced by bacteria with either narrow or broad spectrum activity. Many genome mining studies have indicated that bacteriocin gene clusters are widespread within certain gut microbiota members. In early life, Bifidobacterium comprise the dominant microbiota genus in vaginally delivered and breast-fed infants, with high levels associated with improved health. However, in many cases the mechanisms underlying these beneficial effects are unknown, although a limited number of studies have suggested that bacteriocin production by Bifidobacterium may represent a key mechanism for preventing pathogen over-growth. Here, we used BAGEL4 and antiSMASH to identify putative bacteriocin sequences in the whole genome sequences of 33 Bifidobacterium strains isolated from infants participating in two clinical studies. We identified a novel non-lantibiotic bacteriocin from Bifidobacterium longum subsp. infantis LH_664, with 40% sequence homology to Lactococcin 972 from Lactococcus lactis subsp. lactis. The putative bacteriocin (Bifidococcin_664) was chemically synthesized and studied for antimicrobial and immune-modulatory activities. We determined it has discrete activity against Clostridium perfringens and it appears to have novel immune stimulatory activities, promoting macrophage phagocytosis and specific cytokine release. These data highlight strain-specific beneficial properties in the early life genus Bifidobacterium, and suggest avenues for development of novel and highly specific dual action antimicrobials, and possible probiotic strains, that are active against clinically important bacterial pathogens. Data summarySamples LH_9 to LH_666 were previously sequenced and deposited to ENA under accession numbers ERS2658025-ERS2658043. Samples LH_986 to LH_1052 are newly sequenced and deposited to NCBI under accession numbers SAMN24838598-SAMN24838611. Additionally, previously assembled publicly available sequences (n=7) were retrieved online from NCBI Genomes database. See Supplementary Table S1 for further details.
- organism: human
- assay: metagenomics
- research focus: cell type annotation
- research focus: differential expression
- approach: biophysical modeling
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Production of multiple bacteriocins, including the novel bacteriocin gassericin M, by Lactobacillus gasseri LM19, a strain isolated from human milk
E. Garcia-Gutierrez, P. M. O'Connor, … A. Narbad·bioRxiv·Nov 13, 2019
- Systematically investigating and identifying bacteriocins in the human gut microbiome
Dengwei Zhang, Yinai Zou, … Yong‐Xin Li·Cell GenomicsPeer-reviewed·Sep 2, 2025
- Health-associated gut bacteriocins target TLR4 to suppress intestinal inflammation
Yuqi Shi, Xiang Fang, … Yong‐Xin Li·bioRxiv·Jul 23, 2026
- Angicin, a novel bacteriocin of Streptococcus anginosus
V. Vogel, R. Bauer, … B. Spellerberg·bioRxiv·Sep 8, 2021
- Isolation and Characterization of Bacteriocin-Producing Lactic Acid Bacteria from Cheese and Functional Evaluation of Their Synthesized Bioactive Peptides
Christian Kosisochukwu Anumudu, Taghi Miri, Helen N. Onyeaka·bioRxiv·Aug 18, 2026
- Identification, Characterization and Mode of Action of Corynaridin, a Novel Linaridin from Corynebacterium lactis
E. Pashou, S. J. Reich, … O. Goldbeck·bioRxiv·May 11, 2022